Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Women with Angina and Metabolic Syndrome (IRMA)
NCT02252406Phase 4Completed
- Sponsor
- University of Florida
- Start
- Sep 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in stable angina, metabolic syndrome, sponsored by University of Florida. Started Sep 2015; status: completed.
02
Drugs
ranolazine
03
Conditions
stable anginametabolic syndrome
Beyond the preview
Go deeper on NCT02252406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252406.